
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1035 | 1179 | 935 | 739 | 841 | 1235 |
Fund Return | 3.5% | 17.85% | -6.48% | -9.61% | -3.4% | 2.13% |
Place in category | 10 | 22 | 46 | 138 | 100 | 40 |
% in Category | 11 | 10 | 34 | 86 | 79 | 44 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Selectra J Lamarck Biotech Class B | 80.09M | 2.70 | -10.72 | 1.09 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Pictet Biotech I EUR | 1.53B | -1.39 | 3.53 | 2.75 | ||
Pictet Biotech P EUR | 1.53B | -1.97 | 2.61 | 1.87 | ||
Pictet Biotech R EUR | 1.53B | -2.43 | 1.88 | 1.16 | ||
LU1120766388 | 1.46B | -4.18 | 3.24 | 4.61 | ||
FCP MEDICAL BioHealth-Trends EUR | 693.19M | -3.05 | 4.39 | 7.27 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Ionis Pharma | US4622221004 | 9.76 | 69.96 | +1.48% | |
Biogen | US09062X1037 | 9.65 | 150.97 | -0.81% | |
Alnylam | US02043Q1076 | 5.52 | 450.74 | -1.92% | |
Swedish Orphan Biovitrum | SE0000872095 | 4.95 | 312.20 | -0.70% | |
Crispr Therapeutics | CH0334081137 | 4.87 | 76.80 | +8.75% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review